Medifast, Inc. (MED) Misses Q1 EPS by 8c
Tweet
Share
E-mailGet Alerts MED Hot Sheet
Price: $33.50 -0.21%
Revenue Growth %: -41.0%
Financial Fact:
Cost of sales: 16.42M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Revenue Growth %: -41.0%
Financial Fact:
Cost of sales: 16.42M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Medifast, Inc. (NYSE: MED) reported Q1 EPS of $0.29, $0.08 worse than the analyst estimate of $0.37. Revenue for the quarter came in at $88.9 million versus the consensus estimate of $85.75 million.
For earnings history and earnings-related data on Medifast, Inc. (MED) click here.
For earnings history and earnings-related data on Medifast, Inc. (MED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Arca Biopharma (ABIO) Reports Q1 Loss of $0.14
- AptarGroup (ATR) Tops Q1 EPS by 11c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
